Dynavax Technologies
DVAX
$11.20
Share price
1.08%
Change (1 day)
-5.56%
Change (1 year)
Categories
Dynavax Technologies (DVAX) - Total assets
Total assets on the balance sheet as of March 2023 : $0.96 B
According to Dynavax Technologies 's latest financial reports the company's total assets are $0.96 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Dynavax Technologies - Total assets on balance sheet (from 2003 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.98 B | -5.14% |
| 2021-12-31 | $1.03 B | 194.18% |
| 2020-12-31 | $0.35 B | 26.59% |
| 2019-12-31 | $0.27 B | 32.33% |
| 2018-12-31 | $0.21 B | -3.61% |
| 2017-12-31 | $0.21 B | 99.48% |
| 2016-12-31 | $0.10 B | -49.37% |
| 2015-12-31 | $0.21 B | 56.65% |
| 2014-12-31 | $0.13 B | -32.42% |
| 2013-12-31 | $0.20 B | 46.42% |
| 2012-12-31 | $0.13 B | 4.21% |
| 2011-12-31 | $0.13 B | 59.17% |
| 2010-12-31 | $84.24 M | 66.93% |
| 2009-12-31 | $50.47 M | -44.31% |
| 2008-12-31 | $90.62 M | -24.76% |
| 2007-12-31 | $0.12 B | 17.07% |
| 2006-12-31 | $0.10 B | 28.46% |
| 2005-12-31 | $80.09 M | 8.75% |
| 2004-12-31 | $73.64 M | 133.17% |
| 2003-12-31 | $31.58 M | 0.34% |
| 2002-12-31 | $31.47 M | 108.23% |
| 2001-12-31 | $15.11 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $197.20 B | 20,232.05% | 🇺🇸 USA |
 Amgen AMGN | $88.72 B | 9,047.13% | 🇺🇸 USA |
 Biogen BIIB | $24.59 B | 2,436.12% | 🇺🇸 USA |
 Gilead Sciences GILD | $61.87 B | 6,279.48% | 🇺🇸 USA |
 Merck MRK | $109.16 B | 11,154.51% | 🇺🇸 USA |
 AstraZeneca AZN | $96.68 B | 9,868.53% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $72.58 B | 7,383.54% | 🇬🇧 UK |
 Agenus
AGEN | $0.41 B | -57.36% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $44.00 B | 4,437.07% | 🇮🇱 Israel |